Proteins pattern alteration in AZT-treated K562 cells detected by two-dimensional gel electrophoresis and peptide mass fingerprinting

Proteome Science

Volumn 4, Issue , 2006, Pages

  D'Andrea, Gabriele ^a   Lizzi, Anna R ^a   Venditti, Sara ^a   Di Francesco, Laura ^b   Giorgi, Alessandra ^b   Mignogna, Giuseppina ^b   Oratore, Arduino ^a   Bozzi, Argante ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HEAT SHOCK PROTEIN 60; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN DISULFIDE ISOMERASE; STATHMIN; SUPEROXIDE DISMUTASE; ZIDOVUDINE;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; EXTRACTION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 33645784878     PISSN: 14775956     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-4-4     Document Type: Article

References (59)

1. Mitsuya H, Weinhold KJ, Furman PA, Clair MH St, Lehrman SN, Gallo RC, Bolognesi D, Barry DW, Broder S: 3′-azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy associated virus in vitro. Proc Natl Acad Sci USA 1985, 82:7096-7100.
2. De Clercq E: New developments in anti-HIV chemotherapy. Biochim Biophys Acta 2002, 1587:258-275.
3. Cooper EC: Antiretroviral combination treatment prolongs life in people with HIV/AIDS. AMFAR Re 1996. Jan 1-5
4. Del Rio C, Hernandez-Tepichin GH: Optimism rises on combination therapy and protease inhibitor data. AIDS Clin Care 1996, 8:19-20.
5. Mattioli B, Giordani L, Quaranta MG, Viora M: Effect of indinavir used alone or in double or triple combination with AZT and ddC on human immune functions. Life Sci 2004, 74:2291-2300.
6. Hall ET, Yan JP, Melancon P, Kuchta RD: 3′-azido-3′-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity. J Biol Chem 1994, 269:14355-14358.
7. Yan JP, Ilsley DID, Frohlick C, Steet R, Hall ET, Kuchta RD, Melancon P: 3'-Azidothymidine (zidovudine) inhibits glycosylation and dramatically alters glycosphingolipid synthesis in whole cells at clinically relevant concentrations. J Biol Chem 1995, 270:22836-22841.
8. D'Andrea G, Lizzi AR, Brisdelli F, D'Alessandro AM, Bozzi A, Oratore A: Protein glycans alteration and a different distribution of some enzymatic activities involved in the glycan processing are found in AZT-treated K562 cells. Mol Cell Biochem 2003, 252:45-51.
9. Lutton J.D, Mathew A, Levere RD, Abraham NG: Role of heme metabolism in AZT-induced bone marrow toxicity. Am J Hematol 1990,35:1-5.
10. Szabados E, Fisher GM, Toth K, Csete B, Nemeti B, Trombitas K, Habon T, Enclei D, Sumegi B: Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med 1999, 26:309-317.
11. Valenti D, Atlante A, Barile M, Passarella S: Inhibition of phosphate transport in rat heart mitochondria by 3′-azido-3′-deoxythymidine due to stimulation of superoxide anion mitochondrial production. Biochem Pharmacol 2002, 64:201-206.
12. Yamaguchi T, Katoh I, Kurata SI: Azidothymidine causes functional and structural destruction of mitochondria, glutathione deficiency and HIV-1 promoter sensitization. Eur J Biochem 2002, 269:2782-2788.
13. Collier AC, Helliwell RJ, Keelan JA, Paxton JW, Mitchell MD, Tingle MD: 3′-azido-3′-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta. Toxicol Appl Pharmacol 2003, 192:164-173.
14. Bridges EG, Trentesaux C, Lahlil R, Spiga MG, Jeannesson P, Sommadossi JP: 3′-azido-3′-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells. Eur J Haematol 1996, 56:62-67.
15. Komarov AM, Hall JM, Weglicki WB: Azidothymidine promotes free radical generation by activated macrophages and hydrogen peroxide-iron-mediated oxidation in a cell-free system. Biochim Biophys Acta 2004, 1688:257-264.
16. Olivero OA, Tejera AM, Fernandez JJ, Taylor BJ, Das S, Divi RL, Poirier MC: Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis 2005, 20:139-146.
17. Kurokawa M, Ghosh SK, Ramos JC, Mian AM, Toomey NL, Cabral L, Whitby D, Barber GN, Dittmer DP, Harrington WJ Jr: Azidothymidine inhibits NF-kB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood 2005, 106:23S-240.
18. Marty R, Ouameur AA, Neault JF, Nafisi S, Tajmir-Riahi HA: AZT-DNA interaction. DNA Cell Biol 2004, 23:135-140.
19. Iwamoto T, Hiraku Y, Oikawa S, Mizutani H, Kojima M, Kawanishi S: Oxidative DNA damage induced by photodegradation products of 3′-azido-3′-deoxythymidine. Arch Biochem Biophys 2003, 416:155-163.
20. Slamenova D, Horvathova E, Bartkova M: Nature of DNA lesions induced in human hepatoma cells, human colonic cells and human embryonic lung fibroblasts by the antiretroviral drug 3′-azido-3′-deoxythymidine. Mutat Res 2006,593:97-107.
21. De la Asuncion JG, Del Olmo ML, Gomez-Cambronero LG, Sastre J, Pallardo FV, Vina J: AZT induces oxidative damage to cardiac mitochondria: protective effect of vitamins C and E. Life Sci 2004, 76:47-56.
22. Ji HJ, Rha SY, Jeung HC, Yangm SH, An SW, Chung HC: Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss. Breast Cancer Res Treat 2005, 93:227-236.
23. Pan G, Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM: AZT enhances osteoclastogenesis and bone loss. AIDS Res Hum Retroviruses 2004, 20:608-620.
24. Freyssenet D, Di Carlo M, Escobar P, Grey J, Schneider J, Hood DA: Zidovudine (AZT) induced alterations in mitochondrial biogenesis in rat striated muscles. Can J Physiol Pharmacol 1999, 77:29-35.
25. Rasband WS: ImageJ. 1997 [http:/rsb.info.nih.gov/ij/]. U.S. National Institutes of Health, Bethesda, Maryland, USA
26. Abramoff MD, Magelhaes PJ, Ram SJ: Image Processing with ImageJ. Biophotonics International 2OO4, 11:36-42.
27. Neuhoff V, Stamm R, Eibl H: Clear background and highly sensitive protein staining with Coomassie Blue dyes in polyacrylamide gels: A systematic analysis. Electrophoresis 1985, 6:427-448.
28. Neuhoff V, Stamm R, Pardowitz I, Arold N, Ehrhardt W, Taube D: Essential problems in quantification of proteins following colloidal staining with coomassie brilliant blue dyes in polyacrylamide gels, and their solution. Electrophoresis 1990, 11:101-117.
29. LaMantia M, Lennarz WJ: The essential function of yeast protein isomerase does not reside in its isomerase activity. Cell 1993, 74:899-908.
30. Laboissiere MC, Sturley SL, Raines RT: The essential function of protein-disulfide isomerase is to unscramble non-native disulfide bonds. J Biol Chem 1995, 270:28006-28009.
31. Gilbert HF: Protein disulfide isomerase. Methods 1998, 290:26-50.
32. Freedman RB, Dunn AD, Ruddock LW: Protein folding: a missing redox link in the endoplasmic reticulum. Curr 1998, 8:R468-R470.
33. Wilkinson B, Gilbert HF: Protein disulfide isomerase. Biochim 2004, 1699:35-44.
34. Markovic I, Stantchev TS, Fields KH, Tiffany LJ, Tomic M, Weiss CD, Broder CC, Strebel K, Clouse KA: Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-I envelope-mediated T-cell fusion during viral entry. Blood 2004, 103:1586-1594.
35. Barbouche R, Miquelis R, Jones IM, Fenouillet E: Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J Biol Chem 2003, 278:3131-3136.
36. Gallina A, Hanley TM, Mandel R, Trahey M, Broder CC, Viglianti GA, Ryser HJ: Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem 2002, 277:50579-50588.
37. Guo GG, Patel K, Kumar V, Shah M, Fried VA, Etlinger JD, Sehgal PB: Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ ERp57) with Stat3 in cytosol and plasma membrane complexes. J Interferon Cytokine Res 2002, 22:555-563.
38. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C: The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 2005, 25:2793-2802.
39. Mukhopadhyay S, Shah M, Patel K, Sehgal PB: Monocrotaline pyrrole-induced megalocytosis of lung and breast epithelial cells: Disruption of plasma membrane and Golgi dynamics and an enhanced unfolded protein response. Toxicol Appl Pharmacol 2005 in press. Jul 4
40. Larsson N, Segerman B, Howell B, Fridell K, Cassimeris L, Gullberg M: Op 18/stathmin mediates multiple region-specific tubulin and microtubule-regulating activities. J Cell Biol 1999, 146:1289-1302.
41. Munier A., Serres C, Kann ML, Boissan M, Lesaffre C, Capeau J, FouquetJP, Lacombe ML: Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility. Exp Cell Res 2003, 289:295-306.
42. Pinon VP, Millot G, Munier A, Vassy J, Linares-Cruz G, Capeau J, Calvo F, Lacombe ML: Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit. Exp Cell Res 1999, 246:355-367.
43. Wellner RB, Pless DD, Thompson WL: Characterization of 3′-azido-3′-deoxythymidine inhibition of ricin and Pseudomonas exotoxin A toxicity in CHO and Vero cells. J Cell Physiol 1994, 159:495-505.
44. Morimoto RI, Tissieres A, Georgopoulos G: The biology of heat-shock proteins and molecular chaperones. New York: Cold Spring Harbor Laboratory Press; 1994.
45. Poccia F, Piselli P, Vendetti S, Bach S, Amendola A, Placido R, Colizzi V: Heat-shock protein expression on the membrane of T cells undergoing apoptosis. Immunology 1996, 88:6-12.
46. Soltys BJ, Gupta RS: Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. Exp Cell Res 1996, 222:16-27.
47. Langer T, Pfeifer G, Martin J, Baumeister W, Hard FU: Chaperonin-mediated protein folding: GroES binds to one end of the GroEL cylinder, which accommodates the protein substrate within its central cavity. EMB0 J 1992, 11:4757-4765.
48. Speth C, Prohaszka Z, Mair M, Stockl G, Zhu X, Jobstl B, Fust G, Dierich MP: A 60 kD heat-shock protein-like molecule interacts with the HIV transmembrane glycoprotein gp41. Mol Immunol 1999,36:619-628.
49. Parissi V, Calmels C, De Soultrait VR, Caumont A, Fournier M, Chaignepain S, Litvak S: Functional interactions of human immunodeficiency virus type I integrase with human and yeast HSP60. J Virol 2001, 75:11344-11353.
50. Bannister JV, Bannister WH, Rotilo G: Aspects of the structure, function and application of superoxide dismutase. CRC Critical Rev Biochem 1987, 22:110-180.
51. Weisiger RA, Fridovich I: Superoxide dismutase. Organelle specificity. J Biol Chem 1973, 248:3582-3592.
52. Prakash O, Teng S, Ali M, Zhu X, Coleman R, Dabdoub RA, Chambers R, Aw TY, Flores SC, Joshi BH: The human immunodeficiency virus type I Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. Arch Biochem Biophys 1997, 343:173-180.
53. Treitinger A, Spada C, Verdi JC, Miranda AF, Oliveira OV, Silveira MV, Moriel P, Abdalla DS: Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur j Clin Invest 2000, 30:454-459.
54. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
55. Bjellqvist B, Sanchez JC, Pasquali C, Ravier F, Paquet N, Frutiger S, Hughes GJ, Hochstrasser D: Micropreparative two-dimensional electrophoresis allowing the separation of samples containing milligram amounts of proteins. Electrophoresis 1993, 14:1375-1378.
56. Cecconi D, Astner H, Donadelli M, Calmieri M, Missiaglia E, Hamdan M, Scarpa A, Righetti PG: Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine. Electrophoresis 2003, 24:4291-4303.
57. Sanchez JC, Appel R, Golaz OG, Pasquali C, Ravier F, Bairoch A, Hochstrasser DF: Inside SWISS-2DPAGE database. Electrophoresis 1995, 16:1131-1151.
58. Lehner I, Niehof M, Borlak J: An optimized method for the isolation and identification of membrane proteins. Electrophoresis 2003, 24:1795-1808.
59. Vuadens F, Crettaz D, Telenti A, Quadroni M, Duchosal MA, Schneider P, Tissot JD: New insights into HIV lymphocyte infection. In Biomedical Application of Proteomics Edited by: Sanchez JC, Corthals GL, Hochstrasser DF. Weinheim: Wiley-VCH; 2004:245-262.